[Code of Federal Regulations]
[Title 42, Volume 3]
[Revised as of October 1, 2004]
From the U.S. Government Printing Office via GPO Access
[CITE: 42CFR486.306]

[Page 626-628]
 
                         TITLE 42--PUBLIC HEALTH
 
  CHAPTER IV--CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF 
                  HEALTH AND HUMAN SERVICES (CONTINUED)
 
PART 486_CONDITIONS FOR COVERAGE OF SPECIALIZED SERVICES FURNISHED BY 
SUPPLIERS--Table of Contents
 
   Subpart G_Conditions for Coverage: Organ Procurement Organizations
 
Sec. 486.306  Qualifications for designation as an OPO.

    To be designated as the OPO for a service area, an organization 
must, at the time of application and throughout the period of its 
designation, meet the following requirements:
    (a) Be a nonprofit entity that is exempt from Federal income 
taxation under section 501 of the Internal Revenue Code of 1986.
    (b) Have accounting and other fiscal procedures necessary to assure 
the fiscal stability of the organization, including procedures to obtain 
payment for kidneys and non-renal organs provided to transplant centers.

[[Page 627]]

    (c) Have an agreement with the Secretary to be reimbursed under 
Medicare for the procurement of covered organs.
    (d) Document that it has a defined service area that meets the 
requirements of Sec. 486.307.
    (e) Have a director and such other staff, including an organ 
donation coordinator and an organ procurement specialist, necessary to 
obtain organs effectively from donors in its service area.
    (f) Have a board of directors or an advisory board that has the 
authority to recommend policies relating to the donation, procurement, 
and distribution of organs. While an OPO may have more than one board, 
the members specified in paragraphs (f)(1) through (f)(5) of this 
section must be members of a single board. The board of directors or 
advisory board must be composed of the following:
    (1) Members who represent hospital administrators, tissue banks, 
voluntary health associations in its service area and either intensive 
care or emergency room personnel.
    (2) Members who represent the public residing in that area.
    (3) A physician with knowledge, experience, or skill in the field of 
human histocompatibility, or an individual with a doctorate degree in a 
biological science and with knowledge, experience, or skills in the 
field of human histocompatibility.
    (4) A neurosurgeon or another physician with knowledge or skills in 
the field of neurology.
    (5) A transplant surgeon from each transplant center in its service 
area with which the OPO has arrangements to coordinate its activities.
    (g) To identify potential organ donors, have documented evidence 
that--(1) It has a working relationship with at least 75 percent of the 
hospitals that participate in the Medicare and Medicaid programs in its 
service area and that have an operating room and the equipment and 
personnel for retrieving organs; and
    (2) It conducts systematic efforts intended to acquire all usable 
organs from potential donors.
    (h) Arrange for the appropriate tissue typing of donated organs.
    (i) Have a system to equitably allocate donated organs among 
transplant patients that is consistent with--
    (1) ``Guidelines for Preventing Transmission of Human 
Immunodeficiency Virus Through Transplantation of Human Tissue and 
Organs'' issued by the Centers for Disease Control and Prevention (CDC) 
that are appended to this subpart; and
    (2) Rules of the Organ Procurement and Transplantation Network 
(OPTN), see Sec. 486.308.
    (j) Provide or arrange for the transportation of donated organs to 
transplant centers.
    (k) Have arrangements to coordinate its activities with transplant 
centers in the area.
    (l) Have arrangements to cooperate with tissue banks for the 
retrieval, processing, preservation, storage and distribution of tissues 
as may be appropriate to assure that all usable tissues are obtained 
from potential donors.
    (m) Maintain and make available upon request of the Secretary, the 
Comptroller General, or their designees data that relate to the 
performance standards.
    (n) Maintain data in a format that can be readily used by a 
successor OPO and agree to turn over to the Secretary copies of all 
records and data necessary to assure uninterrupted service by a 
successor OPO newly designated by CMS.
    (o) Have a procedure for ensuring the confidentiality of patient 
records. Information from or copies of records may be released only to 
authorized individuals and the OPO must ensure that unauthorized 
individuals cannot gain access to or alter patient records. Original 
medical records may be released by the OPO only in accordance with 
Federal or State laws, court orders, or subpoenas.
    (p) Conduct and participate in professional education concerning 
organ procurement.
    (q) Ensure that appropriate donor screening and infection tests, 
consistent with OPTN standards and the CDC guidelines that are appended 
to this subpart, are performed by a laboratory that is certified in the 
appropriate specialty or subspecialty of service in accordance with part 
493 of this

[[Page 628]]

chapter, including tests to prevent the acquisition of organs that are 
infected with the etiologic agent for acquired immune deficiency 
syndrome.
    (r) Assist hospitals in establishing and implementing protocols for 
making routine inquiries about organ donations by potential donors.
    (s) Ensure that donors are tested for human immunodeficiency viral 
markers consistent with OPTN rules and the CDC guidelines appended to 
this subpart for solid organ donation.
    (t) Submit accurate data to CMS within 15 days following the end of 
a calendar year (unless otherwise notified) giving information on the 
following:
    (1) Population of designated service area based on the most recent 
U.S. Bureau of the Census data.
    (2) Number of actual donors.
    (3) Number of kidneys procured.
    (4) Number of kidneys transplanted.
    (5) Number of extrarenal organs by type procured.
    (6) Number of extrarenal organs by type transplanted.

[53 FR 6550, March 1, 1988; 53 FR 9172, March 21, 1988; 53 FR 18987, May 
26, 1988; 57 FR 7137, Feb. 28, 1992; 59 FR 46515, Sept. 8, 1994. 
Redesignated and amended at 60 FR 50447, 50448, Sept. 29, 1995; 61 FR 
19743, May 2, 1996]